Publications by authors named "A Cherrez"
Introduction: Up to 25% of children and 5.6% of adults in the USA have atopic dermatitis (AD), with substantial impacts on quality of life. Effective control can be challenging despite therapy efforts.
View Article and Find Full Text PDFBackground: Patient-reported outcome measures (PROMs) are validated and standardized tools that complement physician evaluations and guide treatment decisions. They are crucial for monitoring atopic dermatitis (AD) and chronic urticaria (CU) in clinical practice, but there are unmet needs and knowledge gaps regarding their use in clinical practice.
Objecctive: We investigated the global real-world use of AD and CU PROMs in allergology and dermatology clinics as well as their associated local and regional networks.
Objetive: To assess cutaneous reactions after Pfizer-BioNTech COVID-19 vaccine administration.
Methods: A cross-sectional observational study was carried out in health workers belonging to the city of Guayaquil-Ecuador, from March to May 2021. The participants were contacted through a local registry established by the Universidad Espíritu Santo.
Article Synopsis
- Chronic urticaria (CU) patients show a significant interest in using mobile apps to monitor their disease activity and control, with over half expressing high levels of interest in app usage.
- A study involving 1841 CU patients from 17 countries found that a majority have chronic spontaneous urticaria (CSU) and are predominantly female and urban-dwelling.
- The findings suggest that the development of tailored and expert-validated apps for different urticaria types could enhance disease management and inform future research efforts.